Literature DB >> 35382130

What can we learn from Fli1-deficient mice, new animal models of systemic sclerosis?

Yoshihide Asano1.   

Abstract

Systemic sclerosis is a complex multifactorial disease characterized by autoimmunity, vasculopathy, and selective organ fibrosis. A series of genetic and epidemiological studies have demonstrated that environmental influences play a central role in the onset of systemic sclerosis, while genetic factors determine the susceptibility to and the severity of this disease. Therefore, the identification of predisposing factors related to environmental influences would provide us with an informative clue to better understand the pathological process of this disease. Based on this concept, the deficiency of transcription factor Friend leukemia virus integration 1, which is epigenetically suppressed in systemic sclerosis, seems to be a potential candidate acting as the predisposing factor of this disease. Indeed, Fli1-mutated mice serve as a set of useful disease models to disclose the complex pathology of systemic sclerosis. This article overviews the recent advancement in systemic sclerosis animal models associated with Friend leukemia virus integration 1 deficiency.
© The Author(s) 2018.

Entities:  

Keywords:  Endothelial cells; Fli1; KLF5; Keratinocytes; Systemic sclerosis

Year:  2018        PMID: 35382130      PMCID: PMC8892875          DOI: 10.1177/2397198318758221

Source DB:  PubMed          Journal:  J Scleroderma Relat Disord        ISSN: 2397-1983


  55 in total

1.  Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis.

Authors:  Ling Lei; Cheng Zhao; Fang Qin; Zhi-Yi He; Xu Wang; Xiao-Ning Zhong
Journal:  Clin Exp Rheumatol       Date:  2016-01-11       Impact factor: 4.473

2.  Ets transcription factors cooperate with Sp1 to activate the human tenascin-C promoter.

Authors:  F Shirasaki; H A Makhluf; C LeRoy; D K Watson; M Trojanowska
Journal:  Oncogene       Date:  1999-12-16       Impact factor: 9.867

3.  Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1.

Authors:  Y Ben-David; E B Giddens; K Letwin; A Bernstein
Journal:  Genes Dev       Date:  1991-06       Impact factor: 11.361

4.  DNA demethylation of CD40l in CD4+ T cells from women with systemic sclerosis: a possible explanation for female susceptibility.

Authors:  XiaoRi Lian; Rong Xiao; XinHong Hu; Takuro Kanekura; HongYan Jiang; YaPing Li; YaoYao Wang; Yan Yang; Ming Zhao; QianJin Lu
Journal:  Arthritis Rheum       Date:  2012-07

5.  Interleukin-13 stimulates the transcription of the human alpha2(I) collagen gene in human dermal fibroblasts.

Authors:  Masatoshi Jinnin; Hironobu Ihn; Kenichi Yamane; Kunihiko Tamaki
Journal:  J Biol Chem       Date:  2004-07-22       Impact factor: 5.157

6.  Potential roles of interleukin-17A in the development of skin fibrosis in mice.

Authors:  Yoshinobu Okamoto; Minoru Hasegawa; Takashi Matsushita; Yasuhito Hamaguchi; Doanh Le Huu; Yoichiro Iwakura; Manabu Fujimoto; Kazuhiko Takehara
Journal:  Arthritis Rheum       Date:  2012-11

7.  Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: association of interleukin 12 elevation with spontaneous regression of skin sclerosis.

Authors:  Takashi Matsushita; Minoru Hasegawa; Yasuhito Hamaguchi; Kazuhiko Takehara; Shinichi Sato
Journal:  J Rheumatol       Date:  2006-02       Impact factor: 4.666

8.  Transcription factor Fli1 regulates collagen fibrillogenesis in mouse skin.

Authors:  Yoshihide Asano; Margaret Markiewicz; Masahide Kubo; Gabor Szalai; Dennis K Watson; Maria Trojanowska
Journal:  Mol Cell Biol       Date:  2008-11-10       Impact factor: 4.272

9.  Epigenetic repression of bone morphogenetic protein receptor II expression in scleroderma.

Authors:  Yongqing Wang; Bashar Kahaleh
Journal:  J Cell Mol Med       Date:  2013-07-16       Impact factor: 5.310

10.  Abnormally differentiating keratinocytes in the epidermis of systemic sclerosis patients show enhanced secretion of CCN2 and S100A9.

Authors:  Joanna Nikitorowicz-Buniak; Xu Shiwen; Christopher P Denton; David Abraham; Richard Stratton
Journal:  J Invest Dermatol       Date:  2014-06-16       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.